Novatec Vial
Cagrilintide Vial 5mg
Cagrilintide is a long-acting amylin analogue studied for satiety signalling, appetite regulation and body-composition research.
£159
£31.80/mg
- Tracked delivery — UK typically 2–3 working days, EU 3–7.
- 1 third-party lab report on file
- Card payment at checkout, verified by your bank.
Product data
- Brand
- Novatec
- Format
- Vial
- Strength
- 5mg
- Compound
- Cagrilintide
- SKU
- MYO-VIAL-CAGRI-5MG
Handling — Vial
- Lyophilised (freeze-dried) powder in a sealed vial.
- Reconstitution is done by the researcher; bacteriostatic water is listed separately.
- Store refrigerated at 2–8°C and protect from light, as printed on the vial.
About this product
Cagrilintide is a long-acting amylin analogue explored in metabolic research for its role in satiety signalling and appetite regulation. It acts on a pathway distinct from the GLP-1 compounds it is most often studied alongside.
Because it targets appetite through a separate mechanism, cagrilintide is usually examined in combination protocols rather than on its own — pairing it with a GLP-1 or triple-agonist peptide addresses appetite by more than one route.
Research focus
- Long-acting amylin analogue
- Satiety-signalling research
- Appetite-regulation pathways
- Combination metabolic protocols
Supplied by NOVATEC as a purity-tested, single-dose lyophilised vial. For research purposes only — not for human or veterinary use.
Third-party testing
Lab reports
Issued by Janoshik Analytical for the peptide in this product. Each opens on the lab's own verification page.
All reports on file →Related products